Immunohistochemistry (IHC) Antibodies
Antibodies for IHC, IF, Multiplex IHC, and Spatial Proteomics
Over 50,000 IHC-validated antibodies tested on human tissues help you generate reproducible, publication-ready staining in demanding pathology and research workflows, including IF, multiplex immunostaining and spatial proteomics.
Explore OriGene's three flagship antibody brands - UltraMAB, TrueMAB, and TrueRAB, each built for specificity, sensitivity, and consistent IHC performance.
- 50,000+ IHC-validated antibodies for normal and disease tissues
- 19,000+ OriGene-branded antibody clones with extensive validation and citations
- Unconjugated, BSA & Azide-free options available
- Commercial licensing opportunity available
- Easy IHC reagent search with gene-based navigation and matched controls

Why OriGene Antibodies Matter in IHC
Antibody specificity is critical in IHC, where false-positive stainig can mislead biomaker interpretation and clinical research decisions. OriGene uses multi-layered validation strategies to ensure antibodies recognize the intended target.
Multi-Platform Validation
Extensive Tissue Testing
Peer-Reviewed Citations
Specialized IHC Solutions
Discover antibodies validated for your specific research area, with citations and application data to support your work.
IHC-Validated Antibodies for Immunology & Oncology Research
Immuno-oncology reseach depends on robust IHC antibodies to profile immune checkpoints, tumor-infiltrating lymphocytes, and tumor antigens in FFPE biopsies.
KEY TARGETS
- Checkpoint molecules: CTLA-4, PD-1, PD-L1
- Cancer-testis antigen: MAGE-A4 (clone OTI1F9)
- Adhesion markers: CD146 (MCAM)
IHC-Validated Antibodies for Neurology & Brain Research
IHC is central to mapping protein expression across brain regions, characterizing neuronal and glial populations, and tracking neurodegeneration.
KEY TARGETS
- Neuronal markers and receptors
- Ion channels and signaling proteins
- Glial cell markers
IHC, IF Antibodies in Citations







Integrated IHC Controls & Samples
Find all the companion materials needed for successful IHC experiments: tissue samples, microarrays, and control
Custom Development
Extend Your IHC Workflow
For emerging biomarkers or proprietary targets, OriGene's custom antibody development services provide tailor-made monoclonal antibodies optimized for IHC.
Antigen design and production using full-length human proteins expressed in HEK293T cells
Comprehensive validation packages including Western blot, IHC on tissue panels, and IF
Customizable screening and selection criteria based on your application requirements
Expert consultation throughout the development process
| IHC Resources |